Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

HSIC vs DXPE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8.13B
5Y Perf.+16.6%
DXPE
DXP Enterprises, Inc.

Industrial - Distribution

IndustrialsNASDAQ • US
Market Cap$2.42B
5Y Perf.+785.9%

HSIC vs DXPE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HSIC logoHSIC
DXPE logoDXPE
IndustryMedical - DistributionIndustrial - Distribution
Market Cap$8.13B$2.42B
Revenue (TTM)$13.18B$2.06B
Net Income (TTM)$398M$88M
Gross Margin29.1%31.7%
Operating Margin5.8%8.7%
Forward P/E13.2x25.5x
Total Debt$3.69B$982M
Cash & Equiv.$156M$304M

HSIC vs DXPELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HSIC
DXPE
StockMay 20May 26Return
Henry Schein, Inc. (HSIC)100116.6+16.6%
DXP Enterprises, In… (DXPE)100885.9+785.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: HSIC vs DXPE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: DXPE leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Henry Schein, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
HSIC
Henry Schein, Inc.
The Income Pick

HSIC is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 1 yrs, beta 0.72
  • Lower volatility, beta 0.72, Low D/E 76.9%, current ratio 1.38x
  • Beta 0.72, current ratio 1.38x
Best for: income & stability and sleep-well-at-night
DXPE
DXP Enterprises, Inc.
The Growth Play

DXPE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 11.9%, EPS growth 27.0%, 3Y rev CAGR 10.8%
  • 7.3% 10Y total return vs HSIC's 5.8%
  • 11.9% revenue growth vs HSIC's 4.0%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthDXPE logoDXPE11.9% revenue growth vs HSIC's 4.0%
ValueHSIC logoHSICLower P/E (13.2x vs 25.5x)
Quality / MarginsDXPE logoDXPE4.3% margin vs HSIC's 3.0%
Stability / SafetyHSIC logoHSICBeta 0.72 vs DXPE's 1.70, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)DXPE logoDXPE+80.6% vs HSIC's +2.8%
Efficiency (ROA)DXPE logoDXPE5.6% ROA vs HSIC's 3.6%, ROIC 12.5% vs 7.1%

HSIC vs DXPE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M
DXPEDXP Enterprises, Inc.
FY 2025
Service Centers
68.1%$1.4B
Innovative Pumping Solutions
19.4%$390M
Supply Chain Services
12.5%$253M

HSIC vs DXPE — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDXPELAGGINGHSIC

Income & Cash Flow (Last 12 Months)

DXPE leads this category, winning 4 of 6 comparable metrics.

HSIC is the larger business by revenue, generating $13.2B annually — 6.4x DXPE's $2.1B. Profitability is closely matched — net margins range from 4.3% (DXPE) to 3.0% (HSIC).

MetricHSIC logoHSICHenry Schein, Inc.DXPE logoDXPEDXP Enterprises, …
RevenueTrailing 12 months$13.2B$2.1B
EBITDAEarnings before interest/tax$1.1B$209M
Net IncomeAfter-tax profit$398M$88M
Free Cash FlowCash after capex$561M$71M
Gross MarginGross profit ÷ Revenue+29.1%+31.7%
Operating MarginEBIT ÷ Revenue+5.8%+8.7%
Net MarginNet income ÷ Revenue+3.0%+4.3%
FCF MarginFCF ÷ Revenue+4.3%+3.4%
Rev. Growth (YoY)Latest quarter vs prior year+7.7%+9.5%
EPS Growth (YoY)Latest quarter vs prior year+14.9%-2.4%
DXPE leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

HSIC leads this category, winning 6 of 6 comparable metrics.

At 21.7x trailing earnings, HSIC trades at a 26% valuation discount to DXPE's 29.1x P/E. On an enterprise value basis, HSIC's 10.9x EV/EBITDA is more attractive than DXPE's 14.4x.

MetricHSIC logoHSICHenry Schein, Inc.DXPE logoDXPEDXP Enterprises, …
Market CapShares × price$8.1B$2.4B
Enterprise ValueMkt cap + debt − cash$11.7B$3.1B
Trailing P/EPrice ÷ TTM EPS21.66x29.14x
Forward P/EPrice ÷ next-FY EPS est.13.25x25.52x
PEG RatioP/E ÷ EPS growth rate6.87x
EV / EBITDAEnterprise value multiple10.90x14.38x
Price / SalesMarket cap ÷ Revenue0.62x1.20x
Price / BookPrice ÷ Book value/share1.80x5.15x
Price / FCFMarket cap ÷ FCF14.18x44.91x
HSIC leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

DXPE leads this category, winning 7 of 9 comparable metrics.

DXPE delivers a 17.9% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $8 for HSIC. HSIC carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to DXPE's 1.97x. On the Piotroski fundamental quality scale (0–9), DXPE scores 7/9 vs HSIC's 4/9, reflecting strong financial health.

MetricHSIC logoHSICHenry Schein, Inc.DXPE logoDXPEDXP Enterprises, …
ROE (TTM)Return on equity+8.2%+17.9%
ROA (TTM)Return on assets+3.6%+5.6%
ROICReturn on invested capital+7.1%+12.5%
ROCEReturn on capital employed+9.8%+14.0%
Piotroski ScoreFundamental quality 0–947
Debt / EquityFinancial leverage0.77x1.97x
Net DebtTotal debt minus cash$3.5B$678M
Cash & Equiv.Liquid assets$156M$304M
Total DebtShort + long-term debt$3.7B$982M
Interest CoverageEBIT ÷ Interest expense4.59x2.89x
DXPE leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DXPE leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in DXPE five years ago would be worth $48,898 today (with dividends reinvested), compared to $8,536 for HSIC. Over the past 12 months, DXPE leads with a +80.6% total return vs HSIC's +2.8%. The 3-year compound annual growth rate (CAGR) favors DXPE at 85.5% vs HSIC's -3.9% — a key indicator of consistent wealth creation.

MetricHSIC logoHSICHenry Schein, Inc.DXPE logoDXPEDXP Enterprises, …
YTD ReturnYear-to-date-7.8%+45.0%
1-Year ReturnPast 12 months+2.8%+80.6%
3-Year ReturnCumulative with dividends-11.3%+538.5%
5-Year ReturnCumulative with dividends-14.6%+389.0%
10-Year ReturnCumulative with dividends+5.8%+732.1%
CAGR (3Y)Annualised 3-year return-3.9%+85.5%
DXPE leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HSIC and DXPE each lead in 1 of 2 comparable metrics.

HSIC is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than DXPE's 1.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DXPE currently trades 85.0% from its 52-week high vs HSIC's 79.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHSIC logoHSICHenry Schein, Inc.DXPE logoDXPEDXP Enterprises, …
Beta (5Y)Sensitivity to S&P 5000.72x1.70x
52-Week HighHighest price in past year$89.29$183.76
52-Week LowLowest price in past year$61.95$75.58
% of 52W HighCurrent price vs 52-week peak+79.3%+85.0%
RSI (14)Momentum oscillator 0–10034.342.7
Avg Volume (50D)Average daily shares traded1.2M175K
Evenly matched — HSIC and DXPE each lead in 1 of 2 comparable metrics.

Analyst Outlook

DXPE leads this category, winning 1 of 1 comparable metric.

Wall Street rates HSIC as "Hold" and DXPE as "Hold". Consensus price targets imply 20.6% upside for HSIC (target: $85) vs -1.4% for DXPE (target: $154).

MetricHSIC logoHSICHenry Schein, Inc.DXPE logoDXPEDXP Enterprises, …
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$85.43$154.00
# AnalystsCovering analysts327
Dividend YieldAnnual dividend ÷ price+0.0%
Dividend StreakConsecutive years of raises14
Dividend / ShareAnnual DPS$0.01
Buyback YieldShare repurchases ÷ mkt cap+10.5%+0.7%
DXPE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

DXPE leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HSIC leads in 1 (Valuation Metrics). 1 tied.

Best OverallDXP Enterprises, Inc. (DXPE)Leads 4 of 6 categories
Loading custom metrics...

HSIC vs DXPE: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is HSIC or DXPE a better buy right now?

For growth investors, DXP Enterprises, Inc.

(DXPE) is the stronger pick with 11. 9% revenue growth year-over-year, versus 4. 0% for Henry Schein, Inc. (HSIC). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Henry Schein, Inc. (HSIC) a "Hold" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HSIC or DXPE?

On trailing P/E, Henry Schein, Inc.

(HSIC) is the cheapest at 21. 7x versus DXP Enterprises, Inc. at 29. 1x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 2x.

03

Which is the better long-term investment — HSIC or DXPE?

Over the past 5 years, DXP Enterprises, Inc.

(DXPE) delivered a total return of +389. 0%, compared to -14. 6% for Henry Schein, Inc. (HSIC). Over 10 years, the gap is even starker: DXPE returned +732. 1% versus HSIC's +5. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HSIC or DXPE?

By beta (market sensitivity over 5 years), Henry Schein, Inc.

(HSIC) is the lower-risk stock at 0. 72β versus DXP Enterprises, Inc. 's 1. 70β — meaning DXPE is approximately 134% more volatile than HSIC relative to the S&P 500. On balance sheet safety, Henry Schein, Inc. (HSIC) carries a lower debt/equity ratio of 77% versus 197% for DXP Enterprises, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — HSIC or DXPE?

By revenue growth (latest reported year), DXP Enterprises, Inc.

(DXPE) is pulling ahead at 11. 9% versus 4. 0% for Henry Schein, Inc. (HSIC). On earnings-per-share growth, the picture is similar: DXP Enterprises, Inc. grew EPS 27. 0% year-over-year, compared to 7. 2% for Henry Schein, Inc.. Over a 3-year CAGR, DXPE leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HSIC or DXPE?

DXP Enterprises, Inc.

(DXPE) is the more profitable company, earning 4. 4% net margin versus 3. 0% for Henry Schein, Inc. — meaning it keeps 4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DXPE leads at 8. 8% versus 5. 7% for HSIC. At the gross margin level — before operating expenses — DXPE leads at 31. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HSIC or DXPE more undervalued right now?

On forward earnings alone, Henry Schein, Inc.

(HSIC) trades at 13. 2x forward P/E versus 25. 5x for DXP Enterprises, Inc. — 12. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HSIC: 20. 6% to $85. 43.

08

Which pays a better dividend — HSIC or DXPE?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is HSIC or DXPE better for a retirement portfolio?

For long-horizon retirement investors, Henry Schein, Inc.

(HSIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). DXP Enterprises, Inc. (DXPE) carries a higher beta of 1. 70 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HSIC: +5. 8%, DXPE: +732. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HSIC and DXPE?

These companies operate in different sectors (HSIC (Healthcare) and DXPE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

HSIC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen
Stocks Like

DXPE

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 19%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HSIC and DXPE on the metrics below

Revenue Growth>
%
(HSIC: 7.7% · DXPE: 9.5%)
Net Margin>
%
(HSIC: 3.0% · DXPE: 4.3%)
P/E Ratio<
x
(HSIC: 21.7x · DXPE: 29.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.